Hematopoietic and Lymphoid System Neoplasm Clinical Trials
2 recruiting trials for Hematopoietic and Lymphoid System Neoplasm. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Hematopoietic and Lymphoid System Neoplasm clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by OHSU Knight Cancer Institute (1), Mayo Clinic (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Biospecimen Collection (procedure, 1 trial), followed by Genetic Counseling, Genetic Testing.
Track Hematopoietic and Lymphoid System Neoplasm trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Identifying and Caring for Individuals With Inherited Cancer Syndrome
This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general...
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
This study examines how spinal cord stimulation (SCS) affects pain level and quality of life in patients experiencing chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Hematopoietic and Lymphoid System Neoplasm, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Hematopoietic and Lymphoid System Neoplasm, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Hematopoietic and Lymphoid System Neoplasm, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.